5-Amino-1MQ

Description

5-Amino-1MQ

5-Amino-1MQ is an emerging inhibitor of NNMT (Nicotinamide N-Methyltransferase) currently under investigation for its role in enhancing metabolic function, promoting fat metabolism, boosting NAD+ levels, and regulating cellular energy. In contrast to conventional GLP-1 peptides that primarily suppress appetite, 5-Amino-1MQ acts on metabolic pathways involved in fat storage and energy utilization, which has led to its growing interest in advanced studies on body composition and longevity. It is frequently promoted for its potential to enhance fat burning, support mitochondrial function, and improve overall metabolic efficiency.

Also known as: 5-amino-1-methylquinolinium, NNMT Inhibitor

• Status: Preclinical stage. Evidence based on animal studies.
• Common dosage: 50–75 mg per day, taken once daily in the morning, via subcutaneous injection or oral administration.
• Investigated for effects on fat metabolism, cellular energy production, and body composition.